Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-25-114385
Filing Date
2025-09-12
Accepted
2025-09-12 09:44:42
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A neogen_2025_proxy-add_ma.htm DEFA14A 29961
2 GRAPHIC img259701480_0.jpg GRAPHIC 272196
3 GRAPHIC img259701480_1.jpg GRAPHIC 145349
  Complete submission text file 0000950170-25-114385.txt   606251
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: DEFA14A | Act: 34 | File No.: 000-17988 | Film No.: 251310246
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)